Clinical Trial Update: Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pyrotinib maleate combined with vinorelbine for HER2-positive advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pyrotinib maleate (pyrotinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: HER2-positive Advanced Breast Cancer | Phase 2 | Status: COMPLETED